Full Program

Thursday, April 24

TCTAP Workshops

Management of Ischemic Heart Disease 2025: ISCHEMIA Trial Has Been a Major Inescapable Turning Point

TCTAP Workshops

Management of Ischemic Heart Disease 2025: ISCHEMIA Trial Has Been a Major Inescapable Turning Point

Thursday, April 24
8:10 AM ~ 9:40 AM * KST (UTC/GMT +9:00)
Coronary Theater, Level 1
8:10 AM Left Main and Multi-Vessel Disease Revascularization: Updated Guideline and Beyond 2025
8:18 AM A Novel Ongoing Trial of PCI vs. CABG: RECHARGE
Lecturer: Gregg W. Stone
8:26 AM DM and Three-Vessel Disease: Why We Need New RCTS- DEFINE-DM Trial
Lecturer: Duk-Woo Park
8:34 AM Future Role of Intracoronary Physiology: Beyond FAME Series
Lecturer: Nico Pijls
8:42 AM Unmet Need for FFR in Left Main PCI: FATE-MAIN Trial
Lecturer: Jung-Min Ahn
8:50 AM Master's Key Case and Review: Multi-Vessel PCI in Acute Coronary Syndromes: Decision-Making With FFR or Intracoronary Imaging
Lecturer: Shamir R. Mehta
8:58 AM Panel Discussion I

Master's Opinion - Debate: OMT vs. Surgery for Multi-Vessel Disease in CCS

9:13 AM OMT First
9:21 AM Surgery Is Still Standard
9:29 AM Panel Discussion II
TAVR: Key Issues in 2025
Imaging & Physiology I: Current Status and Future Perspective
Imaging & Physiology II: Insights From Recent Data
CTO Technical Forum: Learn From Masters
Complex PCI: Challenges and Advanced Techniques
This program is subject to change without notice.